SmartMoneyDB

Slate Path Capital LP

NEW YORK, NY · CIK 0001559706

Portfolio Value: $1.32B
Positions: 13
Period: 2014-03-31
Filed: 2014-05-15

Portfolio Value

$1.32B

Positions

13

New

3

Increased

4

Decreased

4

Sold Out

13

Slate Path Capital LP Q1 2014 13F Filing Summary

Slate Path Capital LP (NEW YORK, NY) reported a portfolio value of $1.32B across 13 positions in their Q1 2014 SEC 13F filing (period ending 2014-03-31). Top holdings include TCOM ($159.33M), NDOI ($152.06M), CHTR ($147.22M). The top 10 positions account for 91.1% of the portfolio. This quarter saw 3 new positions, 4 increases, 4 reductions, 13 complete exits. Notable new buys: NDOI ($152.06M), BARRICK GOLD CORP ($142.64M), ARIAD PHARMACEUTICALS INC ($53.36M). Notable exits: NDAQ, YOUKU TUDOU INC, THCH.

All Holdings

#StockValueWeightChange
1
TCOMCTRIP COM INTL LTD
AMERICAN DEP SHS
$159.33M
12.06%
+26.4%
2
NDOIENDO INTL PLC
SHS
$152.06M
11.51%
New
3
CHTRCHARTER COMMUNICATIONS INC D
CL A NEW
$147.22M
11.14%
-
4
MEDGPANDORA MEDIA INC
COM
$146.29M
11.07%
+13.4%
5
BARRICK GOLD CORP
COM
$142.64M
10.79%
New
6
AIGAMERICAN INTL GROUP INC
COM NEW
$135.03M
10.22%
-31.7%
7
MPCMARATHON PETE CORP
COM
$101.84M
7.71%
-59.2%
8
SIRISIRIUS XM HLDGS INC
COM
$92.61M
7.01%
-
9
LNGCHENIERE ENERGY INC
COM NEW
$70.30M
5.32%
-53.6%
10
ZNGAEURZYNGA INC
CL A
$56.42M
4.27%
+3.9%
11
ARIAD PHARMACEUTICALS INC
COM
$53.36M
4.04%
New
12
PBFPBF ENERGY INC
CL A
$36.64M
2.77%
+17.4%
13
ALNYALNYLAM PHARMACEUTICALS INC
COM
$27.63M
2.09%
-58.8%

Position Changes

StockValueShares
NDOIENDO INTL PLC
$152.06M2,215,000
BARRICK GOLD CORP
$142.64M8,000,000
ARIAD PHARMACEUTICALS INC
$53.36M6,620,000